Jackson Hole Capital Partners’s iShares Biotechnology ETF IBB Stock Holding History

Jackson Hole Capital Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-45	Closed	-$5.69K	–	309
2025 Q2	$5.69K	Hold	45	–	–	﹤0.01%	266
2025 Q1	$5.76K	Hold	45	–	–	﹤0.01%	264
2024 Q4	$5.95K	Hold	45	–	–	﹤0.01%	261
2024 Q3	$6.55K	Hold	45	–	–	﹤0.01%	252
2024 Q2	$6.18K	Sell	45 -45	-50%	-$6.01K	﹤0.01%	257
2024 Q1	$12.3K	Hold	90	–	–	﹤0.01%	246
2023 Q4	$12.2K	Hold	90	–	–	﹤0.01%	245
2023 Q3	$11K	Hold	90	–	–	﹤0.01%	234
2023 Q2	$11.4K	Hold	90	–	–	﹤0.01%	250
2023 Q1	$11.6K	Hold	90	–	–	﹤0.01%	272
2022 Q4	$11.8K	Hold	90	–	–	﹤0.01%	236
2022 Q3	$11K	Buy	+90	New	+$11.2K	﹤0.01%	235

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jackson Hole Capital Partners's IBB Position: Q3 2025 in Review

Jackson Hole Capital Partners sold out of iShares Biotechnology ETF (IBB) in Q3 2025, closing a stake of 45 shares — an estimated $5.69K sold.

Jackson Hole Capital Partners first reported a position in IBB in Q3 2022 and held it in 12 quarters. The position peaked at $12.3K in Q1 2024. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

Jackson Hole Capital Partners reported no remaining iShares Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
Jackson Hole Capital Partners sold 45 iShares Biotechnology ETF shares in Q3 2025, an estimated $5.69K.
Jackson Hole Capital Partners first reported a position in iShares Biotechnology ETF in Q3 2022 and held it in 12 quarters.
Jackson Hole Capital Partners's iShares Biotechnology ETF position peaked at $12.3K in Q1 2024.
803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on Jackson Hole Capital Partners's 13F filing for Q3 2025, filed 28 Oct 2025.